Intravenous Magnesium Infusion in Patients Undergoing Cardioversion of Atrial Fibrillation Trial
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The proposed study is designed to evaluate the effect of an intravenous infusion of magnesium
sulfate in facilitating successful cardioversion of atrial fibrillation and in decreasing the
energy threshold (in J) required for successful cardioversion of atrial fibrillation into
sinus rhythm.